Treatment and management of Wilson's disease

Pediatrics International

Volumn 41, Issue 4, 1999, Pages 419-422

  Shimizu, Norikazu ^a,b   Yamaguchi, Yukitoshi ^a   Aoki, Tsugutoshi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

D penicillamine; Low copper diet; Triethylene tetramine; Wilson's disease; Zinc salt

Indexed keywords

COPPER; DIMERCAPROL; PENICILLAMINE; TETRATHIOMOLYBDATE AMMONIUM; TRIENTINE; ZINC DERIVATIVE;

CHELATION; CLINICAL FEATURE; CLINICAL PROTOCOL; COPPER METABOLISM; DIET RESTRICTION; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; EARLY DIAGNOSIS; GENE THERAPY; HUMAN; LIVER TRANSPLANTATION; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; WILSON DISEASE;

EID: 0032765624     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01093.x     Document Type: Review

References (21)

1. 1 Danks DM. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York, 1995; 2211-35.
2. 2 Walshe JM, Penicillamine. A new oral therapy for Wilson's disease. Am. J. Med. 1956; 21: 487-95.
3. 3 Walshe JM. Copper chelation in patients with Wilson's disease. Q. J. Med. 1973; 42: 441.
4. 4 Sternlieb I. Perspective on Wilson's disease. Hepatology 1990; 12: 1234-9.
5. 5 Scheinberg IH, Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am. J. Clin. Nutr. 1996; 63: S842-5.
6. 6 Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch. Neurol. 1987; 44: 490-3.
7. 7 Brewer GJ, Turkey A, Yuzbasiyan-Gurkan V. Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine. Arch. Neurol. 1994; 51: 304-5.
8. 8 Walshe JM. Treatment of Wilson's disease with trienthine (triethylene tetramine) dihydrochloride. Lancet 1982; i: 643.
9. 9 Scheinberg IH, Jaffe ME, Sternlieb I. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N. Engl. J. Med. 1987; 317: 209-13.
10. 10 Suda M, Kubota J, Yamaguchi Y, Fujioka Y, Saito Y, Aoki T. A study of trienthine therapy in Wilson's disease with neurological symptoms. No Hattatsu 1993; 25: 429-34 (in Japanese).
11. 11 Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992; 71: 139-64.
12. 12 Brewer J, Yuzbasiyan-Gurkan V. Wilson's disease: An update, with emphasis on new approaches to treatment. Dig. Dis. 1989; 7: 178-93.
13. 13 Mowat AP. Liver Disorder in Childhood. Butterworth-Heinemann Ltd, Oxford, 1994.
14. 14 Shimizu N, Nakazono H, Takeshita Y et al. Molecular analysis and diagnosis in Japanese patients with Wilson's disease. Pediatr. Int. 1999; 41: this issue.
15. 15 Hiyamuta S, Shimizu K, Aoki T. Early diagnosis of Wilson's disease. Lancet 1993; 342: 56-7.
16. 16 Endo F, Taketa K, Nakamura K et al. Measurement of blood holoceruloplasmin by EIA using a mouse monoclonal antibody directed to holoceruloplasmin. Implication for mass screening of Wilson disease. J. Inherit. Metab. Dis. 1994; 17: 616-20.
17. 17 Shimizu N, Nagayama T, Nakazono H et al. A trial study for neonatal screening system of Wilson's disease in Japan using dried filler papers. In: Lam STS, Pang CCP (eds). Neonatal and perinatal screening: The Asian Pacific perspective. The Chinese University Press, Hong Kong, 1996; 29-32.
18. 4) is an anticopper agent in man. In: Scheinberg IH, Walshe JM (eds). Orphan disease and orphan drugs. Manchester University Press, Manchester, 1985; 76-85.
19. 19 Walshe JM. Wilson's disease patients can be decoppered. Lancet 1989; 334: 228.
20. 20 Lai YR, Sugawara N. Outputs of hepatic copper and cadmium stimulated by tetrathiomolybdate (TTM) injection in Long-Evans Cinnamon (LEC) rats pretreated with cadmium, and in Fischer rats pretreated with copper and cadmium. Toxicology 1997; 120: 47-54.
21. 21 Nagano K, Nakamura K, Umeyama K et al. Gene-mediated expression and partial characterization of ATPase7B in cultured cells. J. Trace Elem. Exp. Med. 1997; 10: 111-17.